Home » North American Arrhythmia Management System (AMS) Market

North American Arrhythmia Management System (AMS) Market By Test Equipment (Electrocardiogram (ECG), Holter monitor) By Site of Origin Atrial (Sinus bradycardia, Premature atrial contractions (PACs), Wandering atrial pacemaker, Atrial tachycardia, Multifocal atrial tachycardia, Supraventricular tachycardia (SVT), Atrial flutter, Atrial fibrillation)-Growth, Future Prospects & Competitive Analysis, 2016 – 2030

Price: $2999

Published: | Report ID: 19680 | Report Format : PDF

Key Highlights of the Report

The North America Arrhythmia Management System (AMS) market is segmented by test equipment, site of origin atrial, type, and country. Electrocardiogram (ECG) is the leading segment by test equipment. Sinus bradycardia is the leading segment by site of origin atrial. Supraventricular tachycardias is expected to have the highest CAGR during the forecast period. The United States is driving the growth of the North America Arrhythmia Management System (AMS) industry.

The key factors driving market growth are the rising prevalence of arrhythmia and the growing geriatric population. The high cost of AMS devices and a scarcity of qualified healthcare workers limit market growth.

In the North American AMS market, changing demographics, notably an aging population, increase the need for personalized care. Arrhythmias are more common in older people, necessitating intensive monitoring and control measures. Patients’ demand for personalized, patient-centered care aid in adopting and expanding AMS technologies and services. The transition in the United States healthcare system towards value-based care and outcome-based reimbursement models is influencing the AMS industry. Quality results, patient satisfaction, and cost-effective care delivery are becoming increasingly important to payers and healthcare systems. AMS systems that demonstrate improved patient outcomes, decreased hospitalizations, and improved arrhythmia treatment are more likely to be adopted and reimbursed.

Design Element 2

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample
CTA Design Element 3

Market Overview

The North American Arrhythmia Management System (AMS) market has been gradually growing in recent years and is expected to grow at a 6.60% CAGR between 2023 and 2030. The market was valued at USD 3.7 billion in 2022 and is expected to expand to USD 5.78 billion by 2030.

What Are the Most Significant Drivers of the North American Arrhythmia Management System (AMS) Market?

The key factors driving the market growth are the rising prevalence of arrhythmia and the growing senior population.

What Are the Major Challenges Facing the North American Arrhythmia Management System (AMS) Market?

The high cost of AMS devices and a scarcity of qualified healthcare workers are the issues limiting market growth.

What Are the Growth Opportunities for the North American Arrhythmia Management System (AMS) Market?

The market’s significant opportunities are the growing demand for remote patient monitoring and telemedicine solutions and a focus on patient education and engagement.

Executive Summary

Overview of the North America Arrhythmia Management System (AMS) Market

Arrhythmia Management Systems (AMS) provides various advantages in diagnosing and treating arrhythmias. AMS detects arrhythmias early by continually monitoring the patient’s heart rhythm. It can detect aberrant heart rhythms or anomalies immediately, allowing for immediate medical intervention and therapy. AMS creates a large amount of data, which can be anonymized and used for research and development. Data from several patients combined can help to advance arrhythmia management approaches, discover new medications, and improve healthcare practices.

Market Definition

The North American Arrhythmia Management System (AMS) market is a market segment focusing on developing, manufacturing, and distributing systems and technologies meant to manage and treat arrhythmias in North American patients. Arrhythmia management systems are a collection of medical devices, software solutions, and services that aid in the detection, monitoring, diagnosis, treatment, and long-term management of various types of arrhythmias.

Market Insights

  • North American demand for Arrhythmia Management Systems (AMS) was valued at USD 3.7 billion in 2022 and is expected to reach USD 5.78 billion in 2030, growing at a CAGR of 6.60% between 2023 and 2030.
  • Electrocardiogram (ECG) is the leading segment by test equipment.
  • Sinus bradycardia is the leading segment by site of origin atrial.
  • Supraventricular tachycardias is expected to have the highest CAGR during the forecast period.
  • The United States is driving the growth of the North America Arrhythmia Management System (AMS) industry.
  • Canada is the second largest country in the North America Arrhythmia Management System (AMS) industry.
  • Mexico is expected to be the fastest-growing country in the North America Arrhythmia Management System (AMS) industry.
  • The key factors driving market growth are the rising prevalence of arrhythmia and the growing geriatric population.
  • The high cost of AMS devices and a scarcity of qualified healthcare workers limit market growth.
  • The market’s significant opportunities are the growing demand for remote patient monitoring and telemedicine solutions and a focus on patient education and engagement.

Segmentation by Test Equipment

  • Electrocardiogram (ECG) is the leading segment by test equipment.
  • The Holter monitor segment is predicted to have the greatest CAGR during the forecast period.

Segmentation by Site of Origin Atrial

  • Sinus bradycardia is the leading segment by site of origin atrial.
  • Other site of origin atrial, such as Premature atrial contractions (PACs), Wandering atrial pacemaker, Atrial tachycardia, Multifocal atrial tachycardia, Supraventricular tachycardia (SVT), Atrial flutter, and Atrial fibrillation (Afib), also contribute to the demand for Arrhythmia Management System (AMS).

Segmentation by Type

  • Supraventricular tachycardias is expected to have the highest CAGR during the forecast period.
  • Other types, such as Ventricular and Bradyarrhythmias, also contribute to the demand for Arrhythmia Management Systems (AMS).

Segmentation by Country

  • The United States is driving the growth of the North America Arrhythmia Management System (AMS) industry.
  • Canada is the second largest country in the North America Arrhythmia Management System (AMS) industry.
  • Mexico is expected to be the fastest-growing country in the North America Arrhythmia Management System (AMS) industry.

The increasing prevalence of arrhythmia in North America drives demand for Arrhythmia Management System (AMS). However, the market is hampered by the high cost of AMS devices.

The Arrhythmia Management System (AMS) market in the United States is dynamic and impacted by industry trends. Collaboration among AMS providers, healthcare institutions, technology businesses, and research organizations is growing. Partnerships enable information sharing, novel solutions creation, and AMS technology integration into existing healthcare systems. Collaboration has the potential to result in the development of comprehensive arrhythmia management ecosystems that provide seamless care and improve patient outcomes.

The AMS market in Canada is increasingly focused on health fairness and accessibility. Efforts are being undertaken to close the access gap to arrhythmia management services in various locations and populations. Addressing impediments to care, such as geographic limits, socioeconomic discrepancies, and cultural considerations, is part of this. AMS providers are trying to ensure all Canadians have equal access to quality arrhythmia management.

North American Arrhythmia Management System (AMS) Market

Increasing prevalence of arrhythmia

The rising occurrence of arrhythmia is a major driver of the North American Arrhythmia Management System (AMS) industry. Arrhythmia is a common cardiac disorder characterized by abnormal heart rhythms, and its frequency has been increasing in recent years. Several factors contribute to the rising prevalence of arrhythmia in North America. These include the aging population, sedentary lifestyles, obesity, high blood pressure, diabetes, and other cardiovascular disorders. Arrhythmia prevalence rises as the population ages, and the prevalence of these risk factors rises.

The rising prevalence of arrhythmia raises the demand for effective management and treatment alternatives, driving the AMS industry forward. Arrhythmia management systems include implantable devices such as pacemakers and implantable cardioverter-defibrillators (ICDs), as well as external monitoring systems. These technologies aid in diagnosing, monitoring, and treating arrhythmia, resulting in better results and a higher quality of life for patients.

Growing geriatric population

North America’s aging population is predisposed to cardiovascular disease, including arrhythmia. As the senior population grows, so will the demand for arrhythmia management solutions. Long-term monitoring and treatment options are frequently required by older persons, which increases the demand for AMS devices and solutions.

Increasing awareness and early diagnosis

A growing understanding of arrhythmia and its related hazards has resulted in earlier detection and treatments. Patients are now more aware of arrhythmia symptoms and seek medical attention immediately. Increased awareness campaigns and instructional activities by healthcare organizations and manufacturers have helped to drive demand for AMS solutions.

High cost of AMS devices

The expense of arrhythmia management methods, like implanted devices and monitoring systems, might substantially impede adoption. These gadgets are frequently costly, damaging individuals, healthcare professionals, and healthcare systems. The high expense of modern AMS technologies may limit access, particularly for patients without adequate insurance coverage or in areas with limited healthcare resources.

Lack of skilled healthcare professionals

Arrhythmia management systems require trained healthcare professionals, such as cardiologists, electrophysiologists, and technicians, to use and apply them effectively. However, there is a skilled professional scarcity in some areas, which can hinder the uptake and utilization of AMS technology. Insufficient training opportunities and the specialized nature of arrhythmia therapy may exacerbate this constraint.

Limited reimbursement coverage

While reimbursement rules might motivate, restricted coverage for specific AMS devices and services may hinder market growth. Insurance companies and government healthcare initiatives may not cover the full cost of all AMS devices and procedures. This limited payment coverage may create cost constraints for patients and healthcare providers, influencing the adoption and use of advanced AMS systems.

Growing demand for remote patient monitoring and telemedicine solutions

Remote patient monitoring systems are becoming increasingly popular. AMS providers can seize this opportunity by developing novel systems that allow continuous monitoring of arrhythmia patients from the comfort of their homes, allowing for early detection of irregularities and prompt care.

Telemedicine is gaining popularity, particularly amid the COVID-19 pandemic. Providers can offer virtual consultations, remote diagnostics, and personalized care to arrhythmia patients by incorporating telemedicine features into their AMS platforms, boosting accessibility and convenience.

Focus on Patient Education and Engagement

Patients’ participation and self-care can be improved by educating them about arrhythmias, self-monitoring procedures, and the significance of sticking to treatment plans. AMS providers can create instructional tools, mobile applications, or interactive platforms to educate patients and encourage active engagement in controlling their disease.

Advancements in wearable devices and sensors

Continuous monitoring of heart rhythms is possible using wearable devices such as smartwatches, ECG monitors, or patches. Patients can wear these devices throughout the day, allowing for real-time surveillance and study of their heart activity. This constant monitoring aids in the early detection of any anomalies or arrhythmias.

Wearable devices allow for long-term data collection, providing a comprehensive picture of a patient’s cardiac activity over time. This long-term data is useful for finding patterns, identifying triggers, and evaluating the efficacy of treatment strategies. It gives healthcare practitioners a complete picture of a patient’s arrhythmia situation.

Competitive Landscape

Key Players

The North American Arrhythmia Management System (AMS) market is extremely competitive, with several notable competitors. The following are some of the market’s leading companies and their market shares:

These companies prioritize product innovation, distribution channel development, and mergers and acquisitions to remain competitive.

The leading competitors in the North American Arrhythmia Management System (AMS) market are always looking for new products and technologies to stay ahead of the competition.

ZOLL Medical Corporation introduced the ZOLL Arrhythmia Management System (AMS) in March 2022. ZOLL AMS augments the ECG information offered by standard MCT devices with biometric data (heart rate, activity, respiration rate, and body position). A new study shows that ZOLL AMS assists clinicians in making more informed patient treatment decisions.

Boston Scientific signed a definitive agreement in January 2021 to acquire Preventice Solutions, Inc. This privately held company provides a full portfolio of mobile cardiac health solutions and services, ranging from ambulatory cardiac monitors (including short and long-term Holter monitors) to cardiac event monitors and mobile cardiac telemetry.

Preventice Solutions launched the BodyGuardian MINI, the smallest, reusable long-term Holter device available for cardiac monitoring, in May 2018.

Summary of Key Findings

  • The key factors driving the market growth are the rising prevalence of arrhythmia and the growing senior population.
  • Market segmented by test equipment, site of origin atrial, type, and country.
  • Electrocardiogram (ECG) is the leading segment by test equipment.
  • Sinus bradycardia is the leading segment by site of origin atrial.
  • Supraventricular tachycardias is expected to have the highest CAGR during the forecast period.
  • The United States is leading the market growth; the market is highly competitive with key players, including Applied Cardiac Systems, AliveCor, Biotronik, and Biotricity.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Future Outlook

  • The North American Arrhythmia Management System (AMS) market has a promising future due to the rising demand for remote patient monitoring and telemedicine solutions.
  • The key factors driving the market growth are the rising prevalence of arrhythmia and the growing senior population.
  • The high cost of AMS devices and a scarcity of qualified healthcare workers limit market growth.
  • To remain productive, key businesses must focus on product innovation, expanding market reach, and maintaining competitive pricing.

Segmentation

  • By Test Equipment
    • Electrocardiogram (ECG)
    • Holter monitor
  • By Site of Origin Atrial
    • Sinus bradycardia
    • Premature atrial contractions (PACs)
    • Wandering atrial pacemaker
    • Atrial tachycardia
    • Multifocal atrial tachycardia
    • Supraventricular tachycardia (SVT)
    • Atrial flutter
    • Atrial fibrillation (Afib)
  • By Type
    • Supraventricular tachycardias
    • Ventricular
    • Bradyarrhythmias
  • By Country
    • United States (US)
    • Canada
    • Mexico

1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Data Modelling
1.3.2.1. Company Share Analysis Model
1.3.2.2. Revenue Based Modelling
1.3.3. Phase III – Primary Research
1.3.4. Research Limitations
1.3.5. Assumptions
1.4. Market Introduction
1.5. Market Research Scope

2. Executive Summary
2.1. Market Snapshot: North America Arrhythmia Management System (AMS) Market
2.2. North America Arrhythmia Management System (AMS) Market, By Test Equipment
2.3. North America Arrhythmia Management System (AMS) Market, By Site of Origin Atrial
2.4. North America Arrhythmia Management System (AMS) Market, By Type
2.5. North America Arrhythmia Management System (AMS) Market, By Country

3. Market Dynamics & Factors Analysis
3.1. Introduction
3.1.1. North America Arrhythmia Management System (AMS) Market Value, 2017-2030, (US$ Bn)
3.1.2. Y-o-Y Growth Trend Analysis
3.2. Market Dynamics
3.2.1. Market Drivers
3.2.2. Market Restraints
3.2.3. Market Opportunities
3.2.4. Major Industry Challenges
3.3. Growth and Development Patterns
3.4. Investment Feasibility Analysis
3.5. Market Opportunity Analysis
3.5.1. Test Equipment
3.5.2. Site of Origin Atrial
3.5.3. Type
3.5.4. Geography

4. Premium Insights
4.1. STAR (Situation, Task, Action, Results) Analysis
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Buyers/Consumers
4.2.3. Bargaining Power of Suppliers
4.2.4. Threat of Substitute Types
4.2.5. Intensity of Competitive Rivalry
4.3. Key Market Trends
4.3.1. Demand Side Trends
4.3.2. Supply Side Trends
4.4. Value Chain Analysis
4.5. Technology Analysis
4.6. Analysis and Recommendations
4.7. Marketing Strategy Analysis
4.7.1. Direct Marketing
4.7.2. Indirect Marketing
4.7.3. Marketing Channel Development Trend

5. Market Positioning of Key Players, 2022
5.1. Company market share of key players, 2022
5.2. Competitive Benchmarking
5.3. Market Positioning of Key Vendors
5.4. Geographical Presence Analysis
5.5. Major Strategies Adopted by Key Players
5.5.1. Key Strategies Analysis
5.5.2. Mergers and Acquisitions
5.5.3. Partnerships
5.5.4. Product Launch
5.5.5. Geographical Expansion
5.5.6. Others

6. Economic Impact Analysis
6.1. Recession Impact
6.1.1. North America
6.2. Ukraine-Russia War Impact
6.2.1. North America
6.3. COVID-19 Impact Analysis
6.3.1. North America

7. North America Arrhythmia Management System (AMS) Market Analysis
7.1. North America Arrhythmia Management System (AMS) Market, by Test Equipment, 2017-2030(US$ Bn)
7.1.1. Overview
7.1.2. SRC Analysis
7.2. North America Arrhythmia Management System (AMS) Market, by Site of Origin Atrial, 2017-2030(US$ Bn)
7.2.1. Overview
7.2.2. SRC Analysis
7.3. North America Arrhythmia Management System (AMS) Market, by Type, 2017-2030(US$ Bn)
7.3.1. Overview
7.3.2. SRC Analysis
7.4. North America Arrhythmia Management System (AMS) Market, by Country, 2017-2030 (US$ Bn)
7.4.1. North America Arrhythmia Management System (AMS) Market, by Country, 2022 Vs 2030 (in%)
7.4.2. U.S.
7.4.2.1. U.S. Arrhythmia Management System (AMS) Market Estimates and Forecast, 2017-2030 (US$ Bn)
7.4.2.2. U.S. Arrhythmia Management System (AMS), By Test Equipment, 2017-2030 (US$ Bn)
7.4.2.3. U.S. Arrhythmia Management System (AMS), By Site of Origin Atrial, 2017-2030 (US$ Bn)
7.4.2.4. U.S. Arrhythmia Management System (AMS), By Type, 2017-2030 (US$ Bn)
7.4.3. Canada
7.4.3.1. Canada Arrhythmia Management System (AMS) Market Estimates and Forecast, 2017-2030 (US$ Bn)
7.4.3.2. Canada Arrhythmia Management System (AMS), By Test Equipment, 2017-2030 (US$ Bn)
7.4.3.3. Canada Arrhythmia Management System (AMS), By Site of Origin Atrial, 2017-2030 (US$ Bn)
7.4.3.4. Canada Arrhythmia Management System (AMS), By Type, 2017-2030 (US$ Bn)
7.4.4. Mexico
7.4.4.1. Mexico Arrhythmia Management System (AMS) Market Estimates and Forecast, 2017-2030 (US$ Bn)
7.4.4.2. Mexico Arrhythmia Management System (AMS), By Test Equipment, 2017-2030 (US$ Bn)
7.4.4.3. Mexico Arrhythmia Management System (AMS), By Site of Origin Atrial, 2017-2030 (US$ Bn)
7.4.4.4. Mexico Arrhythmia Management System (AMS), By Type, 2017-2030 (US$ Bn)

8. Company Profiles
8.1. Applied Cardiac Systems
8.1.1. Company Overview
8.1.2. Products/Services Portfolio
8.1.3. Geographical Presence
8.1.4. Financial Summary
8.1.4.1. Market Revenue and Net Profit (2019-2022)
8.1.4.2. Business Segment Revenue Analysis
8.1.4.3. Geographical Revenue Analysis
8.2. AliveCor
8.3. Biotronik
8.4. Biotricity
8.5. GE Healthcare
8.6. iRhythm Technologies
8.7. Koninklijke Philips N.V.
8.8. Medtronic plc.
8.9. Nihon Kohden Corporation
8.10. St. Jude Medical (Abbott Laboratories)
8.11. Spacelabs Healthcare (OSI Systems Inc.)
8.12. Welch Allyn (Hillrom Services Inc.)

List of Figures
FIG. 1 North America Arrhythmia Management System (AMS) Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom up Approach
FIG. 3 North America Arrhythmia Management System (AMS) Market Segmentation
FIG. 4 North America Arrhythmia Management System (AMS) Market, by Test Equipment, 2022 (US$ Bn)
FIG. 5 North America Arrhythmia Management System (AMS) Market, by Site of Origin Atrial, 2022 (US$ Bn)
FIG. 6 North America Arrhythmia Management System (AMS) Market, by Type, 2022 (US$ Bn)
FIG. 7 North America Arrhythmia Management System (AMS) Market, by Country, 2022 (US$ Bn)
FIG. 8 Attractive Investment Proposition, by Test Equipment, 2022
FIG. 9 Attractive Investment Proposition, by Site of Origin Atrial, 2022
FIG. 10 Attractive Investment Proposition, by Type, 2022
FIG. 11 Attractive Investment Proposition, by Country, 2022
FIG. 12 Market Share Analysis of Key North America Arrhythmia Management System (AMS) Market Manufacturers, 2022
FIG. 13 Market Positioning of Key North America Arrhythmia Management System (AMS) Market Manufacturers, 2022
FIG. 14 North America Arrhythmia Management System (AMS) Market Value Contribution, By Test Equipment, 2022 & 2030 (Value %)
FIG. 15 North America Arrhythmia Management System (AMS) Market, by Electrocardiogram (ECG), Value, 2017-2030 (US$ Bn)
FIG. 16 North America Arrhythmia Management System (AMS) Market, by Holter monitor, Value, 2017-2030 (US$ Bn)
FIG. 17 North America Arrhythmia Management System (AMS) Market Value Contribution, By Site of Origin Atrial, 2022 & 2030 (Value %)
FIG. 18 North America Arrhythmia Management System (AMS) Market, by Sinus bradycardia, Value, 2017-2030 (US$ Bn)
FIG. 19 North America Arrhythmia Management System (AMS) Market, by Premature atrial contractions (PACs), 2017-2030 (US$ Bn)
FIG. 20 North America Arrhythmia Management System (AMS) Market, by Wandering atrial pacemaker, 2017-2030 (US$ Bn)
FIG. 21 North America Arrhythmia Management System (AMS) Market, by Atrial tachycardia, 2017-2030 (US$ Bn)
FIG. 22 North America Arrhythmia Management System (AMS) Market, by Multifocal atrial tachycardia, 2017-2030 (US$ Bn)
FIG. 23 North America Arrhythmia Management System (AMS) Market, by Supraventricular tachycardia (SVT), 2017-2030 (US$ Bn)
FIG. 24 North America Arrhythmia Management System (AMS) Market, by Atrial flutter, 2017-2030 (US$ Bn)
FIG. 25 North America Arrhythmia Management System (AMS) Market, by Atrial fibrillation (Afib), 2017-2030 (US$ Bn)
FIG. 26 North America Arrhythmia Management System (AMS) Market Value Contribution, By Type, 2022 & 2030 (Value %)
FIG. 27 North America Arrhythmia Management System (AMS) Market, by Supraventricular tachycardias, Value, 2017-2030 (US$ Bn)
FIG. 28 North America Arrhythmia Management System (AMS) Market, by Ventricular, 2017-2030 (US$ Bn)
FIG. 29 North America Arrhythmia Management System (AMS) Market, by Bradyarrhythmias, 2017-2030 (US$ Bn)
FIG. 30 North America Arrhythmia Management System (AMS) Market, 2017-2030 (US$ Bn)
FIG. 31 U.S. Arrhythmia Management System (AMS) Market, 2017-2030 (US$ Bn)
FIG. 32 Canada Arrhythmia Management System (AMS) Market, 2017-2030 (US$ Bn)

List of Tables
TABLE 1 Market Snapshot: North America Arrhythmia Management System (AMS) Market
TABLE 2 North America Arrhythmia Management System (AMS) Market: Market Drivers Impact Analysis
TABLE 3 North America Arrhythmia Management System (AMS) Market: Market Restraints Impact Analysis
TABLE 4 North America Arrhythmia Management System (AMS) Market, by Competitive Benchmarking, 2022
TABLE 5 North America Arrhythmia Management System (AMS) Market, by Geographical Presence Analysis, 2022
TABLE 6 North America Arrhythmia Management System (AMS) Market, by Key Strategies Analysis, 2022
TABLE 7 North America Arrhythmia Management System (AMS) Market, by Electrocardiogram (ECG), By Country, 2017-2022 (US$ Bn)
TABLE 8 North America Arrhythmia Management System (AMS) Market, by Electrocardiogram (ECG), By Country, 2023-2030 (US$ Bn)
TABLE 9 North America Arrhythmia Management System (AMS) Market, by Holter monitor, By Country, 2017-2022 (US$ Bn)
TABLE 10 North America Arrhythmia Management System (AMS) Market, by Holter monitor, By Country, 2023-2030 (US$ Bn)
TABLE 11 North America Arrhythmia Management System (AMS) Market, by Sinus bradycardia, By Country, 2017-2022 (US$ Bn)
TABLE 12 North America Arrhythmia Management System (AMS) Market, by Sinus bradycardia, By Country, 2023-2030 (US$ Bn)
TABLE 13 North America Arrhythmia Management System (AMS) Market, by Premature atrial contractions (PACs), By Country, 2017-2022 (US$ Bn)
TABLE 14 North America Arrhythmia Management System (AMS) Market, by Premature atrial contractions (PACs), By Country, 2023-2030 (US$ Bn)
TABLE 15 North America Arrhythmia Management System (AMS) Market, by Wandering atrial pacemaker, By Country, 2017-2022 (US$ Bn)
TABLE 16 North America Arrhythmia Management System (AMS) Market, by Wandering atrial pacemaker, By Country, 2023-2030 (US$ Bn)
TABLE 17 North America Arrhythmia Management System (AMS) Market, by Atrial tachycardia, By Country, 2017-2022 (US$ Bn)
TABLE 18 North America Arrhythmia Management System (AMS) Market, by Atrial tachycardia, By Country, 2023-2030 (US$ Bn)
TABLE 19 North America Arrhythmia Management System (AMS) Market, by Multifocal atrial tachycardia, By Country, 2017-2022 (US$ Bn)
TABLE 20 North America Arrhythmia Management System (AMS) Market, by Multifocal atrial tachycardia, By Country, 2023-2030 (US$ Bn)
TABLE 21 North America Arrhythmia Management System (AMS) Market, by Supraventricular tachycardia (SVT), By Country, 2017-2022 (US$ Bn)
TABLE 22 North America Arrhythmia Management System (AMS) Market, by Supraventricular tachycardia (SVT), By Country, 2023-2030 (US$ Bn)
TABLE 23 North America Arrhythmia Management System (AMS) Market, by Atrial flutter, By Country, 2017-2022 (US$ Bn)
TABLE 24 North America Arrhythmia Management System (AMS) Market, by Atrial flutter, By Country, 2023-2030 (US$ Bn)
TABLE 25 North America Arrhythmia Management System (AMS) Market, by Atrial fibrillation (Afib), By Country, 2017-2022 (US$ Bn)
TABLE 26 North America Arrhythmia Management System (AMS) Market, by Atrial fibrillation (Afib), By Country, 2023-2030 (US$ Bn)
TABLE 27 North America Arrhythmia Management System (AMS) Market, by Supraventricular tachycardias, By Country, 2017-2022 (US$ Bn)
TABLE 28 North America Arrhythmia Management System (AMS) Market, by Supraventricular tachycardias, By Country, 2023-2030 (US$ Bn)
TABLE 29 North America Arrhythmia Management System (AMS) Market, by Ventricular, By Country, 2017-2022 (US$ Bn)
TABLE 30 North America Arrhythmia Management System (AMS) Market, by Ventricular, By Country, 2023-2030 (US$ Bn)
TABLE 31 North America Arrhythmia Management System (AMS) Market, by Bradyarrhythmias, By Country, 2017-2022 (US$ Bn)
TABLE 32 North America Arrhythmia Management System (AMS) Market, by Bradyarrhythmias, By Country, 2023-2030 (US$ Bn)
TABLE 33 North America Arrhythmia Management System (AMS) Market, by Test Equipment, 2017-2022 (US$ Bn)
TABLE 34 North America Arrhythmia Management System (AMS) Market, by Test Equipment, 2023-2030 (US$ Bn)
TABLE 35 North America Arrhythmia Management System (AMS) Market, by Site of Origin Atrial, 2017-2022 (US$ Bn)
TABLE 36 North America Arrhythmia Management System (AMS) Market, by Site of Origin Atrial, 2023-2030 (US$ Bn)
TABLE 37 North America Arrhythmia Management System (AMS) Market, by Type, 2017-2022 (US$ Bn)
TABLE 38 North America Arrhythmia Management System (AMS) Market, by Type, 2023-2030 (US$ Bn)
TABLE 39 North America Arrhythmia Management System (AMS) Market, by Country, 2017-2022 (US$ Bn)
TABLE 40 North America Arrhythmia Management System (AMS) Market, by Country, 2023-2030 (US$ Bn)
TABLE 41 United States Arrhythmia Management System (AMS) Market, by Test Equipment, 2017-2022 (US$ Bn)
TABLE 42 United States Arrhythmia Management System (AMS) Market, by Test Equipment, 2023-2030 (US$ Bn)
TABLE 43 United States Arrhythmia Management System (AMS) Market, by Site of Origin Atrial, 2017-2022 (US$ Bn)
TABLE 44 United States Arrhythmia Management System (AMS) Market, by Site of Origin Atrial, 2023-2030 (US$ Bn)
TABLE 45 United States Arrhythmia Management System (AMS) Market, by Type, 2017-2022 (US$ Bn)
TABLE 46 United States Arrhythmia Management System (AMS) Market, by Type, 2023-2030 (US$ Bn)
TABLE 47 Canada Arrhythmia Management System (AMS) Market, by Test Equipment, 2017-2022 (US$ Bn)
TABLE 48 Canada Arrhythmia Management System (AMS) Market, by Test Equipment, 2023-2030 (US$ Bn)
TABLE 49 Canada Arrhythmia Management System (AMS) Market, by Site of Origin Atrial, 2017-2022 (US$ Bn)
TABLE 50 Canada Arrhythmia Management System (AMS) Market, by Site of Origin Atrial, 2023-2030 (US$ Bn)
TABLE 51 Canada Arrhythmia Management System (AMS) Market, by Type, 2017-2022 (US$ Bn)
TABLE 52 Canada Arrhythmia Management System (AMS) Market, by Type, 2023-2030 (US$ Bn)
TABLE 53 Mexico Arrhythmia Management System (AMS) Market, by Test Equipment, 2017-2022 (US$ Bn)
TABLE 54 Mexico Arrhythmia Management System (AMS) Market, by Test Equipment, 2023-2030 (US$ Bn)
TABLE 55 Mexico Arrhythmia Management System (AMS) Market, by Site of Origin Atrial, 2017-2022 (US$ Bn)
TABLE 56 Mexico Arrhythmia Management System (AMS) Market, by Site of Origin Atrial, 2023-2030 (US$ Bn)
TABLE 57 Mexico Arrhythmia Management System (AMS) Market, by Type, 2017-2022 (US$ Bn)
TABLE 58 Mexico Arrhythmia Management System (AMS) Market, by Type, 2023-2030 (US$ Bn)

Frequently Asked Questions

What is North America’s current market size for Arrhythmia Management Systems (AMS)?

In 2022, the North America Arrhythmia Management System (AMS) market was estimated to be worth USD 3.7 billion.

What will be the growth rate of the North American Arrhythmia Management System (AMS) market between 2023 and 2030?

The North America Arrhythmia Management System (AMS) market is anticipated to develop at a CAGR of 6.60% between 2023 and 2030, reaching USD 5.78 billion in 2030.

Which segment is leading the market in terms of test equipment?

Electrocardiogram (ECG) is the leading segment by test equipment.

Which segment is leading the market in terms of site of origin atrial?

Sinus bradycardia is the leading segment by site of origin atrial.

Which segment is predicted to have the highest CAGR during the forecast period?

Supraventricular tachycardias is expected to have the highest CAGR during the forecast period.

Which country is driving the growth of the North American Arrhythmia Management System (AMS) industry?

The United States is driving the growth of the North America Arrhythmia Management System (AMS) industry.

Who are the key participants in North America’s Arrhythmia Management System (AMS) market?

The top players include Applied Cardiac Systems, AliveCor, Biotronik, and Biotricity. Other major players include GE Healthcare, iRhythm Technologies, and Koninklijke Philips N.V.

What factors drive the North America Arrhythmia Management System (AMS) industry?

The key factors driving the market growth are the rising prevalence of arrhythmia and the growing senior population.

What are the major market restraints in the North American Arrhythmia Management System (AMS) industry?

The high cost of AMS devices and a scarcity of qualified healthcare workers limit market growth.

What are the biggest market opportunities in the North America Arrhythmia Management System (AMS) industry?

The market’s significant opportunities are the growing demand for remote patient monitoring and telemedicine solutions and a focus on patient education and engagement.

Clostridioides Difficile (C. diff) Treatment Market

Published:
Report ID: 33667

Hepatic Encephalopathy Market

Published:
Report ID: 33664

Sphingosine-1-Receptor Modulators Drugs Market

Published:
Report ID: 33649

Guidewires Market

Published:
Report ID: 6790

3D Printing for Personalized Healthcare Market

Published:
Report ID: 33603

Neuromyelitis Optica Therapy Market

Published:
Report ID: 33583

In Vitro Diagnostic (IVD) Kit Market

Published:
Report ID: 33580

North America Medical Headgears Market

Published:
Report ID: 33554

Pediatric Bladder Treatment Market

Published:
Report ID: 33540

Liposomal Amikacin Market

Published:
Report ID: 33532

Tissue Regeneration Scaffold Market

Published:
Report ID: 33486

Life Sciences Aggregate-Spending Market

Published:
Report ID: 33447

Purchase Options

$1999
Delivery Format: Excel.
$2999
Designed for the individual purchaser.
$3999
Users located at a single corporate site or regional office.
$4999
Allowed for unlimited sharing globally within one company.
Smallform of Sample request

Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –

Phone

+91 6232 49 3207


support

24/7 Research Support


sales@credenceresearch.com

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN